Skip to main content

Table 2 Overview of study outcomes

From: Closed Or Open after Source Control Laparotomy for Severe Complicated Intra-Abdominal Sepsis (the COOL trial): study protocol for a randomized controlled trial

 

Indicator

Timeline

Primary outcome

Mortality

90 days

Secondary outcomes

 Logistical

Days free of ICU

30 days

Days free of ventilation

30 days

Days free of RRTa

30 days

Days free of hospital

30 days

 Physiological

APACHE IIb scores

Up to 30 daysc

SOFAd scores

Up to 30 daysc

Pa02/Fi02e ratios

Up to 30 daysc

ARDSf scores

Up to 30 daysc

 Safety

Enterocutaneous fistula

30 days

ACSg and/or severe IAHh

30 days

Intra-abdominal abscess

30 days

 Biological

Il-6

Up to 30 daysi

IL-10

Up to 30 daysi

Procalcitonin

Up to 30 daysi

Activated protein C

Up to 30 daysi

High mobility group box protein 1

Up to 30 daysi

Mitochondrial DNA

Up to 30 daysi

C3a and C5a

Up to 30 daysi

 Microbiological

Intra-abdominal

Up to 30 daysj

Microbiological cultures

 

 Mass cytometry

Intra-peritoneal inflammatory cells

Up to 30 daysk

 Economic

Micro-costed resource consumption

1 year

 Quality of life

Euroqol EQ-5D-5L

90 days and 1 year

SF-36

90 days and 1 year

  1. aRRT renal replacement therapy
  2. bAcute Physiology and Chronic Health Evaluation Score
  3. cMeasured daily using the worst value of that day
  4. dSOFA Sequential Organ Failure Assessment
  5. ePa0 2 /Fi0 2 partial pressure of oxygen over inspired fraction of oxygen
  6. fARDS Acute Respiratory Distress Syndrome
  7. gACS Abdominal Compartment Syndrome
  8. hIAH intraabdominal hypertension
  9. iMeasured as per Table 3
  10. jMeasured as clinically indicated by the treating team
  11. kMeasured on intra-peritoneal fluid obtained in Calgary